Focused On-demand Library for Protein kinase C gamma type

Focused On-demand Libraries - Receptor.AI Collaboration


Explore the Potential with AI-Driven Innovation

Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.


We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by Reaxense.


The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.


We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.


 

Fig. 1. The screening workflow of Receptor.AI

It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.


Key features that set our library apart include:


  • The Receptor.AI platform integrates extensive information about the target protein, such as historical experiments, academic research, known ligands, and structural insights, thereby increasing the likelihood of identifying highly relevant compounds.

  • The platform’s sophisticated molecular simulations are designed to discover potential binding sites, ensuring that our focused library is optimal for the discovery of allosteric inhibitors and binders for cryptic pockets.

  • With over 50 customisable AI models, verified through extensive testing in commercial drug discovery and research, Receptor.AI is efficient, reliable, and precise. These models are essential in the production of our focused libraries.

  • Receptor.AI not only produces focused libraries but also provides full services and solutions at every stage of preclinical drug discovery, with a success-based pricing structure that aligns our interests with the success of your project.

PARTNER
Receptor.AI
 
UPACC
P05129

UPID:
KPCG_HUMAN

ALTERNATIVE NAMES:
-

ALTERNATIVE UPACC:
P05129; B7Z8Q0

BACKGROUND:
The Protein kinase C gamma type, essential in regulating synaptic plasticity, excitotoxicity, memory, and learning, is activated in various stress responses and modulates neurotransmission and cell survival. It is crucial in the development of the cerebellum and plays a significant role in pain mechanisms and ethanol sensitivity.

THERAPEUTIC SIGNIFICANCE:
Given its critical role in Spinocerebellar ataxia 14 and its broad involvement in neuronal function and survival mechanisms, targeting PKC gamma offers a promising avenue for developing treatments for neurodegenerative diseases and conditions related to pain, addiction, and ischemic injury.

Looking for more information on this library or underlying technology? Fill out the form below and we will be in touch with all the details you need.


Page 170 of 8789